What is the role of glatiramer acetate in the treatment of multiple sclerosis during pregnancy?

Updated: Aug 20, 2019
  • Author: Carmel Armon, MD, MSc, MHS; Chief Editor: Stephen A Berman, MD, PhD, MBA  more...
  • Print


An abstract presented at a meeting of the American Academy of Neurology (AAN) in 2003 suggested that glatiramer acetate imposes no substantial risks in pregnancy and has no abortifacient or teratogenic effects. This drug is not known to be excreted in breast milk. Evidence suggests that glatiramer acetate might be safe in pregnancy and breastfeeding. However, caution should be exercised if one decides to treat patients with this drug.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!